SOLID Drug Development SA (SDD) is a strategic and operational consultancy for the development of biotech and pharmaceutical products. Operating from Geneva, Switzerland, SDD undertakes the entire process of drug development – from laboratory to market. SDD'a approach substantially increases the value of a project by expertly facilitating its movement from the lab to its animal and then clinical proof of concept. This allows the drug sponsor to invest in that particular project per se instead of spending money in building dedicated internal teams or infrastructures. Such an approach greatly reduces costs and operational problems for young but also large pharmaceutical companies. Solid Drug Development's expertise ranges across CMC, including technology transfers, non-clinical, clinical, regulatory and strategic concerns.